Today: 20 June 2026

NIO Stock Rollercoaster: Record EV Sales, Lawsuit Shock, and What’s Next for the Tesla Rival

NIO Stock Rollercoaster: Record EV Sales, Lawsuit Shock, and What’s Next for the Tesla Rival

NIO delivered a record 87,071 vehicles in Q3 2025, up 40.8% year-on-year, lifting its stock to $7.70 in early October. On Oct. 16, Singapore’s GIC sued NIO for allegedly inflating $600 million in revenue, triggering a 10% intraday stock plunge to $6.30. Shares remain about 50% higher than at the start of 2025. Investor sentiment is split amid ongoing losses, a fraud lawsuit, and fierce competition.
16 October 2025
···
Sea Limited (SE) Stock Tumbles Nearly 10% as Analysts Debate Shopee’s Growth vs. High Valuation

Sea Limited Stock’s Wild Ride: SE Surges 300% Then Plunges – What’s Next for Shopee’s Tech Giant?

Sea Limited shares fell 9.6% to $163.42 on Oct. 15, 2025, after a sharp rally that brought the stock near its 52-week high. Q2 revenue rose 38.2% to $5.26 billion, with all three core units reporting strong growth. Shopee remains profitable and expanding, while Garena’s Free Fire saw an 18% jump in paying users. Competition from Lazada, TikTok Shop, and new Indonesian taxes pose headwinds.
16 October 2025
···
Microvast Stock Skyrockets 19% on $125M Equity Raise & Battery Breakthroughs

Microvast (MVST) Stock Hits New High on Battery Breakthroughs and $125 M Funding – What’s Next?

Microvast Holdings (NASDAQ: MVST) hit a 52-week high of $6.42 on Oct. 16, up 119% year-to-date and over 2,600% from last year’s lows. The EV battery maker reported record Q2 revenue of $91.3 million and positive adjusted EBITDA, but remains unprofitable. Microvast raised up to $125 million in an equity offering this month. Analyst ratings are mixed, with a consensus price target below current levels.
16 October 2025
··
Inside Salesforce’s Generative AI Revolution: How Marketing GPT and Einstein GPT Are Reshaping CRM

Salesforce Stock Soars on Bold $60B 2030 Target; Analysts See Big Upside

Salesforce shares rose nearly 5% in pre-market trading Oct. 16, following CEO Marc Benioff’s $60 billion revenue target announcement at Dreamforce. CRM closed at $236.58 on Oct. 15, after hitting a multi-month low of $235.69 earlier in October. The stock remains down about 27–28% year-to-date. Salesforce reported $10.2 billion Q2 revenue and expanded its buyback program to $50 billion.
16 October 2025
··
Omeros Stock Explodes 146% on Surprise $2.1B Novo Nordisk Deal – What Comes Next?

Biotech Bombshell: Omeros Stock Skyrockets on $2.1B Novo Nordisk Deal – What’s Next?

Omeros shares soared 150% to $10.42 on Oct. 15 after Novo Nordisk agreed to license its drug zaltenibart (OMS906) for $340 million upfront and up to $2.1 billion in milestones and royalties. Trading volume hit 89.2 million shares, far above average. Omeros reported a Q2 net loss of $25.4 million and $28.7 million in cash as of June 30. Its lead asset narsoplimab remains under FDA and EMA review.
16 October 2025
···
Menopause Launch Sends Hims & Hers (HIMS) Stock Soaring – What’s Next?

Menopause Launch Sends Hims & Hers (HIMS) Stock Soaring – What’s Next?

Hims & Hers shares jumped 16% on Oct. 15 after launching a menopause care program, trading near $62.80 on Oct. 16, up 7% for the day. The stock has more than doubled in 2025, far outpacing rivals like Teladoc. Regulatory scrutiny from the FDA and FTC triggered brief sell-offs in September. Analyst sentiment remains cautious, with most price targets in the high $30s despite recent gains.
16 October 2025
··
RYOJ Stock Rockets 180% Overnight – What’s Fueling the Surge?

RYOJ Stock Rockets 180% Overnight – What’s Fueling the Surge?

RYOJ shares soared 188% after hours to $6.11 on Oct 15, following a 13% gain in regular trading, despite no company news. The Tokyo-based labor-consulting and health-services firm, which debuted on Nasdaq in August at $4.00, now has a market cap near $21.6 million. Trading volume spiked last week as momentum drove the rally. RYOJ operates 28 clinics and 2 salons in Japan.
16 October 2025
·
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 16.10.2025

Centerspace (CSR) shares rose above their 200-day moving average Thursday, reaching $61.16 before settling near $60.75, up 1.5% on the day. InterContinental Hotels Group (IHG) fell below its 200-day moving average of $119.03, trading as low as $118.57 and closing about 1.4% lower at $118.76.
16 October 2025
··
SHOCKING: Asteroid Discovered Just Days Ago Will Buzz Earth TODAY (Closer Than the Moon) – What Experts and Investors Are Saying

SHOCKING: Asteroid Discovered Just Days Ago Will Buzz Earth TODAY (Closer Than the Moon) – What Experts and Investors Are Saying

Asteroid 2025 TP5, discovered Oct. 13, will pass Earth at about 60,300 miles—one-quarter the Moon’s distance—at 20:09 UTC on Oct. 15. The 54-foot object poses no impact risk, according to NASA and ATLAS. It will pass within 74,600 miles of the Moon on Oct. 16. ATLAS detected the asteroid just two days before its closest approach.
16 October 2025
····
TSMC Stock Skyrockets on AI Boom — Analysts See More Upside

TSMC Stock Skyrockets on AI Boom — Analysts See More Upside

TSMC shares closed at $304.71 in New York and NT$1,465.00 in Taipei on Oct. 15, up about 45% year-to-date amid soaring AI chip demand. Preliminary Q3 revenue reached NT$989.9 billion (≈$32.5 billion), up 30% from a year earlier and above forecasts. Analysts expect record quarterly profit and have raised price targets. TSMC’s market cap stands at $1.1 trillion, but geopolitical tensions around Taiwan remain a concern.
16 October 2025
···
MercadoLibre (MELI) Stock Dips Amid Brazil Competition – Analysts Eye Long-Term Upside

MercadoLibre (MELI) Stock Dips Amid Brazil Competition – Analysts Eye Long-Term Upside

MercadoLibre shares fell about 5.1% to $2,048 at midday Oct. 15, extending a drop from late September highs near $2,500. Q2 revenue rose 34% to $6.8 billion, but net income missed estimates due to margin pressure and currency losses. The company is expanding into B2B e-commerce and Brazil’s pharmacy sector. MercadoPago’s credit portfolio nearly doubled year-over-year, though lending is tightening in Brazil and Mexico.
16 October 2025
··
Pinnacle Food Group (PFAI) Stock Explodes 140% on Trade News – What’s Behind the Rally?

Pinnacle Food Group (PFAI) Stock Explodes 140% on Trade News – What’s Behind the Rally?

Pinnacle Food Group (NASDAQ: PFAI) shares soared 139% to close at $4.57 on Oct. 15, following President Trump’s threat of tighter tariffs on Chinese cooking-oil imports. Trading volume hit 6.6 million shares by midday, far above normal levels. The company issued no new press releases or filings, and market watchers called the move speculative. Other agriculture stocks, including Sadot Group and Bunge, also jumped sharply.
16 October 2025
·
Mawson Infrastructure (MIGI) Stock Skyrockets on Crypto Rally and Executive Shakeup

Mawson Infrastructure (MIGI) Stock Skyrockets on Crypto Rally and Executive Shakeup

Mawson Infrastructure (NASDAQ: MIGI) shares surged 13.36% to $1.00 on Oct. 14 and traded near $1.28 by mid-morning Oct. 15, doubling over two weeks amid crypto market swings. The company recently fired CEO Rahul Mewawalla for cause during a fraud lawsuit and secured a Nasdaq compliance extension. Interim CEO Kaliste Saloom now leads. Analysts remain cautious as volatility continues.
16 October 2025
···
First Horizon (FHN) Stock Shocker: CEO’s Merger Hint Sends Shares Tumbling 13%

First Horizon (FHN) Stock Shocker: CEO’s Merger Hint Sends Shares Tumbling 13%

First Horizon shares plunged 13% to about $20 on Oct. 15, 2025, the steepest drop since May 2023, after M&A comments on its earnings call. The bank beat Q3 expectations with adjusted EPS of $0.51 and $889 million in revenue. Analysts raised some price targets but trimmed others; consensus sits near $25.3. FHN’s drop contrasted with a rally in other U.S. bank stocks that day.
16 October 2025
··
Theriva Biologics (TOVX) Stock Soars 92% on Oncolytic Virus Trial News – Can the Rally Last?

Theriva Biologics (TOVX) Stock Soars 92% on Oncolytic Virus Trial News – Can the Rally Last?

Theriva Biologics shares surged 92% to $0.84 on Oct. 15 after reporting its VCN-01 plus chemotherapy met primary survival endpoints in metastatic pancreatic cancer, prompting a planned Phase 3 trial. The company will present expanded VIRAGE Phase 2b data at ESMO 2025 and interim SYN-004 safety results at IDWeek 2025. Theriva held $12.1 million in cash as of June 30, with a $7.5 million offering closed in May.
15 October 2025
Vivakor (VIVK) Stock Surges 75% After $40M Oil Trading Deal – Bulls & Bears Weigh In

Vivakor (VIVK) Stock Surges 75% After $40M Oil Trading Deal – Bulls & Bears Weigh In

Vivakor shares jumped up to 75% on Oct. 15, 2025, with volume topping 230 million after the company announced a $40 million commodity credit facility for its crude-oil trading arm. Nasdaq granted Vivakor a 180-day extension to regain compliance with its $1.00 minimum bid rule. The company rescheduled a special dividend in Adapti shares to Oct. 31. Leadership changes in August brought in new COO and CFO.
15 October 2025
··
1 … 1,899 1,900 1,901 1,902 1,903 … 2,087

Stock Market Today

  • Jim Cramer: SpaceX Meme Stock Rally Stalls Amid Increased Selling Pressure
    June 20, 2026, 1:05 PM EDT. TV host Jim Cramer stated that SpaceX, led by Elon Musk, has lost its meme stock status after failing to sustain recent price gains. Cramer highlighted a two-way market emerging with significant selling activity, preventing continued upward momentum. Analysts had warned about risks tied to SpaceX's rapid rally resembling the 2021 meme stock trend. Investor Gary Black noted options trading allows bets against SpaceX, intensifying downside pressure. Despite this, Musk's net worth soared to $1.3 trillion amid the rally. The development signals caution for investors in highly speculative, hype-driven stocks losing momentum amid balanced buyer-seller dynamics.

Latest articles

Teradyne set to join Nasdaq-100 after shortened week rally

Teradyne set to join Nasdaq-100 after shortened week rally

20 June 2026
Teradyne surged 7.19% to $437.92 ahead of its Nasdaq-100 inclusion before Monday’s open, capping an 8.6% weekly gain driven by AI-linked test demand and index fund buying; with shares near 52-week highs and trading at 81 times earnings, the stock faces a high bar as investors weigh whether AI momentum and passive inflows can sustain further gains.
Go toTop